Hypocalcemia Induced by Raloxifene

Title:Hypocalcemia Induced by Raloxifene

Volume: 7 Issue: 2

Author(s): Thuy D.T. Vu, Suresh Varadarajan, Ego Seeman, George Jerums and Richard J. MacIsaac

Affiliation:

Keywords: Hypocalcemia, raloxifene, vitamin D deficiency.

Abstract: Raloxifene is an anti-resorptive agent used in postmenopausal osteoporosis. This is the first report of the occurrence of clinically significant hypocalcemia following raloxifene treatment in a patient with occult vitamin D deficiency. Since vitamin D deficiency is widely prevalent in the community, screening for vitamin D deficiency and its correction is advisable before the initiation of anti-resorptive therapy.

Cite this article as:

D.T. Vu Thuy, Varadarajan Suresh, Seeman Ego, Jerums George and J. MacIsaac Richard, Hypocalcemia Induced by Raloxifene, Current Drug Safety 2012; 7 (2) . https://dx.doi.org/10.2174/157488612802715654